George Albert Fisher

7 clinical trials · Sponsor

Record	Firm	Date
Epacadostat and Pembrolizumab in Treating Patients With Metastatic or Unresectable Gastroesophageal Junction or Gastric Cancer (NCT03196232)	George Albert Fisher	2017-09-13
A Phase 2 Study of Pertuzumab and Erlotinib for Refractory Pancreatic Adenocarcinoma (NCT01108458)	George Albert Fisher	2010-07-01
Phase 2 Neoadjuvant Doxorubicin and Cyclophosphamide -> Docetaxel With Lapatinib in Stage II/III Her2Neu+ Breast Cancer (NCT00404066)	George Albert Fisher	2006-10-01
Phase 2 Study of Gemzar, Taxol & Avastin Combination as 1st Line Treatment for Metastatic Breast Cancer (NCT00403130)	George Albert Fisher	2006-02-01
Phase I/II Intratumoral DC Immunotherapy With Gemcitabine & XRT in Unresectable Pancreatic Cancer (NCT00547144)	George Albert Fisher	2005-10-01
Phase 1-2 Vatalanib and Gemcitabine in Advanced Pancreatic Cancer (NCT00185588)	George Albert Fisher	2004-10-01
A Phase 1-2 Trial of Cetuximab in Combination With Oxaliplatin, Capecitabine, and Radiation Therapy Followed by Surgery for Locally-advanced Rectal Cancer (NCT00226941)	George Albert Fisher	2004-06-01

Every clearance here is in the API, with alerts when new ones post.